UK close to US$625 million coronavirus vaccine deal with Sanofi, GSK

Britain is close to a 500 million pound (US$624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of a potential Covid-19 vaccine, The Sunday Times reported.Clinical trials are due to start in September and Sanofi has said it expects to get approval by the first half of next year, sooner than previously anticipated.More than 100 vaccines are being developed and tested around the world to stop the Covid-19 pandemic and governments are racing to secure supplies of vaccines…

Read the original article at South China Morning Post